Table 1.

Baseline Study Characteristics

Characteristics	Non-INSTI-Based Regimens n = 19 620	INSTI-Based Regimens n = 22 762	P
Age, mean (SD), y	39.6 (11.1)	37.1 (11.9)	<.001
Males	14 576 (74.3%)	16 609 (73.0%)	.002
Medicaid insured	3254 (16.6%)	4632 (20.4%)	<.001
Polycystic ovarian syndrome	23 (0.12%)	50 (0.22%)	.011
Pancreatitis	91 (0.46%)	110 (0.48%)	.78
Pancreatic malignancy	7 (0.04%)	5 (0.02%)	.40
Cystic fibrosis	2 (0.01%)	1 (0.00%)	.48
Cushing syndrome	1 (0.01%)	0 (0.00%)	.28
Hepatitis B infection	353 (1.8%)	369 (1.62%)	.16
Hepatitis C infection	608 (3.1%)	652 (2.86%)	.16
Pregnancy	468 (2.39%)	294 (1.29%)	<.001
Gestational diabetes	15 (0.08%)	2 (0.01%)	.001
Malnutrition	432 (2.2%)	554 (2.43%)	.11
Cardiovascular disease	704 (3.59%)	793 (3.48%)	.34
Congestive heart failure	95 (0.48%)	118 (0.52%)	.25
Hypertension	3552 (18.10%)	3965 (17.42)	.07
Obesity	438 (2.23%)	1067 (4.69%)	<.001

INSTI, integrase strand transfer inhibitor; SD, standard deviation.